Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Baxter announced receipt of a major R&D grant from the German BMBF’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free HD option for ESRD.
read more
Bellwyck Pharma Services continues to invest in its global reach and capabilities with a recent facility expansion.
read more
Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1.
read more
IQVIA™ announced that Ferring Pharmaceuticals has selected IQVIA Technologies’ OCE platform for global deployment across more than 50 markets.
read more
Dr. Reddy’s has entered into a purchase agreement with Upsher-Smith Laboratories, pursuant to which the company would sell its US and select territory rights for ZEMBRACE®, SYMTOUCH®, and TOSYMRA™.
read more
Exploristics, has announced plans to launch an updated version of its cloud-based data analytics platform for clinical trial design, KerusCloud 2.0, by the end of the summer.
read more
Camargo Pharmaceutical Services announced it will acquire InSymbiosis, a Canadian drug development partner which improves how biopharma companies outsource R&D.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer.
read more
On 22 May 2019 Amgen announced a recommended public cash offer to the shareholders of Nuevolution to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash.
read more
HBM and Erasmus MC, University Medical Center Rotterdam have signed a 10-year MOU to enable a range of joint research activities to develop next generation biotherapeutics.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Crown Bioscience announced four new preclinical translational NASH models in development.
read more
Amcor has announced the successful completion of its acquisition of Bemis Company.
read more